This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Joslin E (1921) The prevention of diabetes mellitus. JAMA 76: 79–84
Tuomilehto J and Lindström J (2003) The major diabetes prevention trials. Curr Diab Rep 3: 115–122
Simpson RW et al. (2004) Prevention of type 2 diabetes mellitus. In International Textbook of Diabetes Mellitus, edn 3 (2 vols) 1899–1913 (Eds De Fronzo RA et al.) Chichester: John Wiley & Sons Ltd
Buchanan TA et al. (2002) Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51: 2796–2803
Lindström J et al. (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368: 1673–1679
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Tuomilehto, J. Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?. Nat Rev Endocrinol 3, 212–213 (2007). https://doi.org/10.1038/ncpendmet0422
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0422